Relay Therapeutics Inc. (RLAY)
NASDAQ: RLAY
· Real-Time Price · USD
3.54
0.15 (4.42%)
At close: Aug 15, 2025, 3:59 PM
3.60
1.80%
After-hours: Aug 15, 2025, 07:53 PM EDT
Relay Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 677K | 7.68M | n/a | n/a | n/a | 10.01M | -1K | 25.2M | 119K | 226K | 253K | 344K | 365K | 419K | 567K | 666K | 844K | 952K |
Cost of Revenue | 1M | n/a | 1.33M | 1.37M | 1.37M | 1.4M | 1.38M | 1.36M | 1.33M | 1.2M | 1.17M | 1.03M | 60.51M | 975K | 1.03M | 44.16M | 45.15M | 30.62M |
Gross Profit | -325K | 7.68M | -7.24M | -1.37M | -1.37M | 8.61M | -73.87M | 23.84M | -1.22M | -971K | -913K | -689K | -60.15M | -556K | -467K | -43.49M | -44.3M | -29.67M |
Operating Income | -76.85M | -84.87M | -84.98M | -96.37M | -100.76M | -90.36M | -92.2M | -73.58M | -106.05M | -101.18M | -72.85M | -85.89M | -77.81M | -62.72M | -67.46M | -60.99M | -193.58M | -42.41M |
Interest Income | 7.11M | 7.81M | 8.97M | 8.27M | 8.55M | 8.95M | 8.7M | 7.84M | 7.56M | 6.94M | 5.37M | 1.71M | 1M | 696K | 267K | 157K | 180K | 226K |
Pretax Income | -70.38M | -77.06M | -76M | -88.11M | -92.21M | -81.39M | -83.5M | -65.73M | -98.5M | -94.24M | -67.5M | -84.17M | -76.79M | -62.05M | -67.46M | -60.83M | -193.4M | -42.18M |
Net Income | -70.38M | -77.06M | -76M | -88.11M | -92.21M | -81.39M | -83.5M | -65.73M | -98.5M | -87.3M | -43.31M | -87.26M | -76.79M | -51.48M | -67.46M | -60.83M | -193.4M | -42.18M |
Selling & General & Admin | 13.63M | 18.74M | 16.9M | 19.75M | 18.77M | 18.4M | 16.77M | 18.48M | 20.12M | 19.58M | 16.37M | 16.07M | 17.46M | 16.07M | 15.55M | 14.68M | 14.42M | 12.73M |
Research & Development | 63.9M | 73.81M | 68.08M | 76.62M | 91.99M | 82.4M | 77.5M | 81.49M | 88.2M | 82.83M | 67.28M | 66.9M | 60.51M | 51.67M | 51.91M | 44.97M | 45.15M | 30.62M |
Other Expenses | n/a | n/a | -1.33M | n/a | n/a | n/a | -75.93M | -1.2M | -14K | -3K | -24K | 7K | 18K | -21K | n/a | 2M | 1K | -5K |
Operating Expenses | 77.52M | 92.55M | 83.64M | 96.37M | 110.76M | 100.81M | 18.33M | 98.78M | 108.32M | 102.41M | 83.65M | 82.97M | 77.98M | 67.73M | 67.45M | 59.66M | 59.57M | 43.36M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -1.37M | -1.4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 77.52M | 92.55M | 84.98M | 96.37M | 100.76M | 100.37M | 92.19M | 98.78M | 108.32M | 102.41M | 83.65M | 82.97M | 77.98M | 67.73M | 67.45M | 59.66M | 59.57M | 43.36M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.94M | -24.19M | 3.09M | n/a | -10.56M | n/a | 157K | 181K | 221K |
Shares Outstanding (Basic) | 171.26M | 169.23M | 167.34M | 140.23M | 132.82M | 130.84M | 122.58M | 122.23M | 121.68M | 121.32M | 120.97M | 110.91M | 108.64M | 108.29M | 102.75M | 92.69M | 91.94M | 90.2M |
Shares Outstanding (Diluted) | 171.26M | 169.23M | 167.34M | 140.23M | 132.82M | 130.84M | 122.58M | 122.23M | 121.68M | 121.32M | 120.97M | 110.91M | 108.64M | 108.29M | 102.75M | 92.69M | 91.94M | 90.2M |
EPS (Basic) | -0.41 | -0.46 | -0.45 | -0.63 | -0.69 | -0.62 | -0.68 | -0.54 | -0.81 | -0.72 | -0.36 | -0.79 | -0.71 | -0.48 | -0.66 | -0.66 | -2.1 | -0.47 |
EPS (Diluted) | -0.41 | -0.46 | -0.45 | -0.63 | -0.69 | -0.62 | -0.68 | -0.54 | -0.81 | -0.72 | -0.36 | -0.79 | -0.71 | -0.48 | -0.66 | -0.66 | -2.1 | -0.47 |
EBITDA | -76.85M | -84.87M | -83.64M | -95M | -110.76M | -90.8M | -92.89M | -73.41M | -106.87M | -100.98M | -82.23M | -81.6M | -76.66M | -66.34M | -66.42M | -57.98M | -57.77M | -41.49M |
EBIT | -70.38M | -77.06M | -84.98M | -96.37M | -112.13M | -92.19M | -94.26M | -74.78M | -108.2M | -102.18M | -83.39M | -82.63M | -77.61M | -67.32M | -67.46M | -60.83M | -193.4M | -42.41M |
Depreciation & Amortization | n/a | 1.21M | 1.33M | 1.37M | 1.37M | 1.4M | 1.38M | 1.36M | 1.33M | 1.2M | 1.17M | 1.03M | 956K | 975K | 1.03M | 1.01M | 960K | 919K |